

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.55706359 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.55706359 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.68559756 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60977876 |
| 5 | axon ensheathment (GO:0008366) | 4.22857750 |
| 6 | ensheathment of neurons (GO:0007272) | 4.22857750 |
| 7 | myelination (GO:0042552) | 4.15354808 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 3.87500556 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.86436114 |
| 10 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.85282746 |
| 11 | leukocyte aggregation (GO:0070486) | 3.84974888 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.83188730 |
| 13 | histone H3-K36 demethylation (GO:0070544) | 3.82780263 |
| 14 | myelin maintenance (GO:0043217) | 3.82031691 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.81992967 |
| 16 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.68492210 |
| 17 | creatine metabolic process (GO:0006600) | 3.66163802 |
| 18 | fatty acid elongation (GO:0030497) | 3.59340683 |
| 19 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.58599029 |
| 20 | protein localization to endosome (GO:0036010) | 3.54338565 |
| 21 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.51174617 |
| 22 | regulation of histone H3-K27 methylation (GO:0061085) | 3.47061174 |
| 23 | response to laminar fluid shear stress (GO:0034616) | 3.35901590 |
| 24 | mannose metabolic process (GO:0006013) | 3.25745662 |
| 25 | NIK/NF-kappaB signaling (GO:0038061) | 3.21421529 |
| 26 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.12446788 |
| 27 | oligodendrocyte differentiation (GO:0048709) | 3.09383608 |
| 28 | asymmetric protein localization (GO:0008105) | 3.07493042 |
| 29 | regulation of defense response to virus by virus (GO:0050690) | 3.05747278 |
| 30 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.05343177 |
| 31 | thymic T cell selection (GO:0045061) | 3.01086479 |
| 32 | regulation of extracellular matrix organization (GO:1903053) | 3.00616322 |
| 33 | apical protein localization (GO:0045176) | 2.97798750 |
| 34 | virion attachment to host cell (GO:0019062) | 2.97337471 |
| 35 | adhesion of symbiont to host cell (GO:0044650) | 2.97337471 |
| 36 | sodium ion export (GO:0071436) | 2.96719269 |
| 37 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.94715875 |
| 38 | negative T cell selection (GO:0043383) | 2.93041458 |
| 39 | positive thymic T cell selection (GO:0045059) | 2.92773947 |
| 40 | adenosine receptor signaling pathway (GO:0001973) | 2.92177087 |
| 41 | activated T cell proliferation (GO:0050798) | 2.91630878 |
| 42 | germinal center formation (GO:0002467) | 2.89817609 |
| 43 | nerve growth factor signaling pathway (GO:0038180) | 2.88915092 |
| 44 | synaptic vesicle maturation (GO:0016188) | 2.88286446 |
| 45 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.87342858 |
| 46 | negative thymic T cell selection (GO:0045060) | 2.87238040 |
| 47 | detection of bacterium (GO:0016045) | 2.87110336 |
| 48 | response to muramyl dipeptide (GO:0032495) | 2.86731620 |
| 49 | positive T cell selection (GO:0043368) | 2.85257901 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.82734786 |
| 51 | regulation of ARF protein signal transduction (GO:0032012) | 2.82213700 |
| 52 | T-helper cell differentiation (GO:0042093) | 2.79024630 |
| 53 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.79024630 |
| 54 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.77218260 |
| 55 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.76412246 |
| 56 | protein targeting to Golgi (GO:0000042) | 2.74111665 |
| 57 | T cell migration (GO:0072678) | 2.73550792 |
| 58 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.73256429 |
| 59 | negative regulation of inclusion body assembly (GO:0090084) | 2.72694074 |
| 60 | T cell selection (GO:0045058) | 2.72103401 |
| 61 | positive regulation of tolerance induction (GO:0002645) | 2.71156052 |
| 62 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71004578 |
| 63 | regulation of interleukin-4 production (GO:0032673) | 2.70993718 |
| 64 | regulation of tolerance induction (GO:0002643) | 2.69926025 |
| 65 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.68719383 |
| 66 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.63162860 |
| 67 | protein palmitoylation (GO:0018345) | 2.62004169 |
| 68 | alpha-beta T cell differentiation (GO:0046632) | 2.61951562 |
| 69 | negative regulation of neurotransmitter transport (GO:0051589) | 2.61649543 |
| 70 | detection of other organism (GO:0098543) | 2.61215475 |
| 71 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.59888826 |
| 72 | regulation of interleukin-5 production (GO:0032674) | 2.59198044 |
| 73 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.58686762 |
| 74 | positive regulation of interleukin-4 production (GO:0032753) | 2.58269563 |
| 75 | histone lysine demethylation (GO:0070076) | 2.56530329 |
| 76 | cellular potassium ion homeostasis (GO:0030007) | 2.55477618 |
| 77 | potassium ion import (GO:0010107) | 2.54602055 |
| 78 | negative regulation of cell killing (GO:0031342) | 2.53746377 |
| 79 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.53746377 |
| 80 | COPI coating of Golgi vesicle (GO:0048205) | 2.53449651 |
| 81 | Golgi transport vesicle coating (GO:0048200) | 2.53449651 |
| 82 | positive regulation of extracellular matrix organization (GO:1903055) | 2.53423066 |
| 83 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.53091446 |
| 84 | regulation of ARF GTPase activity (GO:0032312) | 2.52836561 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.52047023 |
| 86 | establishment of protein localization to Golgi (GO:0072600) | 2.51187075 |
| 87 | positive regulation of granulocyte differentiation (GO:0030854) | 2.50159398 |
| 88 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.49293895 |
| 89 | embryonic process involved in female pregnancy (GO:0060136) | 2.49053930 |
| 90 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48735393 |
| 91 | phospholipid translocation (GO:0045332) | 2.48492610 |
| 92 | lipid translocation (GO:0034204) | 2.48492610 |
| 93 | regulation of beta-amyloid formation (GO:1902003) | 2.48362145 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.47152549 |
| 95 | regulation of regulatory T cell differentiation (GO:0045589) | 2.46902719 |
| 96 | modulation by virus of host process (GO:0019054) | 2.45858714 |
| 97 | signal complex assembly (GO:0007172) | 2.45298308 |
| 98 | cellular response to interleukin-4 (GO:0071353) | 2.45045809 |
| 99 | tolerance induction (GO:0002507) | 2.43733169 |
| 100 | histone demethylation (GO:0016577) | 2.43703565 |
| 101 | L-amino acid import (GO:0043092) | 2.43592042 |
| 102 | response to type I interferon (GO:0034340) | 2.43416405 |
| 103 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.42755336 |
| 104 | photoreceptor cell differentiation (GO:0046530) | 2.42676343 |
| 105 | eye photoreceptor cell differentiation (GO:0001754) | 2.42676343 |
| 106 | macroautophagy (GO:0016236) | 2.42324261 |
| 107 | B cell receptor signaling pathway (GO:0050853) | 2.41752931 |
| 108 | histone H3-K9 demethylation (GO:0033169) | 2.41637213 |
| 109 | ear development (GO:0043583) | 2.41246612 |
| 110 | response to interleukin-15 (GO:0070672) | 2.40478706 |
| 111 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.40468671 |
| 112 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.40433758 |
| 113 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.40246438 |
| 114 | negative regulation of JUN kinase activity (GO:0043508) | 2.39833378 |
| 115 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.39259136 |
| 116 | B cell homeostasis (GO:0001782) | 2.38820690 |
| 117 | type I interferon signaling pathway (GO:0060337) | 2.38755521 |
| 118 | cellular response to type I interferon (GO:0071357) | 2.38755521 |
| 119 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.38321571 |
| 120 | adhesion of symbiont to host (GO:0044406) | 2.37970901 |
| 121 | response to lipoprotein particle (GO:0055094) | 2.37769990 |
| 122 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.36661920 |
| 123 | positive regulation of Rap GTPase activity (GO:0032854) | 2.36042917 |
| 124 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.35325292 |
| 125 | alpha-beta T cell activation (GO:0046631) | 2.34946422 |
| 126 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.33449744 |
| 127 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.33449744 |
| 128 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.32925589 |
| 129 | membrane tubulation (GO:0097320) | 2.32308159 |
| 130 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.31373241 |
| 131 | T cell differentiation involved in immune response (GO:0002292) | 2.30646136 |
| 132 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.30646136 |
| 133 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.30646136 |
| 134 | negative regulation of innate immune response (GO:0045824) | 2.30598305 |
| 135 | regulation of extracellular matrix disassembly (GO:0010715) | 2.29220917 |
| 136 | glycosylceramide metabolic process (GO:0006677) | 2.28529932 |
| 137 | neuronal action potential propagation (GO:0019227) | 2.28298909 |
| 138 | intestinal absorption (GO:0050892) | 2.27681467 |
| 139 | cellular response to interleukin-15 (GO:0071350) | 2.26476355 |
| 140 | potassium ion homeostasis (GO:0055075) | 2.26105456 |
| 141 | astrocyte development (GO:0014002) | 2.24677135 |
| 142 | Golgi to endosome transport (GO:0006895) | 2.24333475 |
| 143 | regulation of interleukin-13 production (GO:0032656) | 2.23495309 |
| 144 | myelination in peripheral nervous system (GO:0022011) | 2.23354613 |
| 145 | peripheral nervous system axon ensheathment (GO:0032292) | 2.23354613 |
| 146 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.22512492 |
| 147 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.22512492 |
| 148 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.22511733 |
| 149 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.21879231 |
| 150 | very long-chain fatty acid metabolic process (GO:0000038) | 2.21621596 |
| 151 | peptide hormone processing (GO:0016486) | 2.21135179 |
| 152 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.20916468 |
| 153 | neuronal ion channel clustering (GO:0045161) | 2.19210617 |
| 154 | intestinal cholesterol absorption (GO:0030299) | 2.18177108 |
| 155 | transmission of nerve impulse (GO:0019226) | 2.16856902 |
| 156 | regulation of collateral sprouting (GO:0048670) | 2.16184607 |
| 157 | regulation of Rap GTPase activity (GO:0032317) | 2.16175529 |
| 158 | positive regulation of glial cell differentiation (GO:0045687) | 2.15622052 |
| 159 | endocrine pancreas development (GO:0031018) | 2.15484853 |
| 160 | T cell receptor signaling pathway (GO:0050852) | 2.15376381 |
| 161 | Leydig cell differentiation (GO:0033327) | 2.14074008 |
| 162 | regulation of lipoprotein metabolic process (GO:0050746) | 2.13563389 |
| 163 | response to hepatocyte growth factor (GO:0035728) | 2.12602202 |
| 164 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.12602202 |
| 165 | regulation of T cell tolerance induction (GO:0002664) | 2.12588288 |
| 166 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.12091737 |
| 167 | response to nerve growth factor (GO:1990089) | 2.12091737 |
| 168 | regulation of cholesterol homeostasis (GO:2000188) | 2.12040412 |
| 169 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.11686589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.93826510 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 2.89942593 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31931893 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.21121826 |
| 5 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20830774 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.19546387 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12080647 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.11335079 |
| 9 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10337707 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.07781332 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.01486114 |
| 12 | UTX_26944678_Chip-Seq_JUKART_Human | 1.94689393 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.93883107 |
| 14 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.91013031 |
| 15 | MAF_26560356_Chip-Seq_TH2_Human | 1.84327077 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.83198225 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73041621 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70016168 |
| 19 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69884104 |
| 20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68889079 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68271334 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.65420555 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63703484 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62923196 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60465168 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59460156 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57142332 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55649081 |
| 29 | * MYB_26560356_Chip-Seq_TH1_Human | 1.55482677 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52350599 |
| 31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51826706 |
| 32 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.51143428 |
| 33 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49824163 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48489070 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47353621 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47243338 |
| 37 | * MYB_26560356_Chip-Seq_TH2_Human | 1.46794033 |
| 38 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.45488107 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41964259 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.41201327 |
| 41 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38877453 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38837824 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38531644 |
| 44 | * P68_20966046_ChIP-Seq_HELA_Human | 1.37984025 |
| 45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37662529 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35914614 |
| 47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34482260 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34213697 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33578538 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32350314 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29882736 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29545264 |
| 53 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29545264 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29348058 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28576610 |
| 56 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27427169 |
| 57 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27210701 |
| 58 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.26834465 |
| 59 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26094563 |
| 60 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25494606 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23154456 |
| 62 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.23019001 |
| 63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22850772 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22082841 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21891213 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21451601 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20437298 |
| 68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20407628 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19025839 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18244944 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17557787 |
| 72 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.16962157 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16677639 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15991503 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14974858 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14304241 |
| 77 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13377152 |
| 78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13041129 |
| 79 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11892502 |
| 80 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.11824033 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11773449 |
| 82 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11697174 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10253109 |
| 84 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.09327019 |
| 85 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08722337 |
| 86 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08566796 |
| 87 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08417030 |
| 88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08083201 |
| 89 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07589714 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07510728 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07177606 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06800961 |
| 93 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.06402826 |
| 94 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05699518 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05108854 |
| 96 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05057034 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04261919 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04131589 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04054101 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03649649 |
| 101 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03108913 |
| 102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02702425 |
| 103 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01174402 |
| 104 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01001214 |
| 105 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00882215 |
| 106 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99822525 |
| 107 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99545976 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98893777 |
| 109 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.97962392 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97606388 |
| 111 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97566421 |
| 112 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97323845 |
| 113 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96504515 |
| 114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96106891 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94933686 |
| 116 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94586754 |
| 117 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94213974 |
| 118 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93652422 |
| 119 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93398614 |
| 120 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93187951 |
| 121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92994183 |
| 122 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92754727 |
| 123 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92715980 |
| 124 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92627367 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92567285 |
| 126 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91334154 |
| 127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.91103747 |
| 128 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90765604 |
| 129 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90145366 |
| 130 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90114930 |
| 131 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.90062940 |
| 132 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89244160 |
| 133 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88342489 |
| 134 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86862439 |
| 135 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.85097062 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84958276 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84110421 |
| 138 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.83803796 |
| 139 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83726367 |
| 140 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.83569655 |
| 141 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83059581 |
| 142 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82800561 |
| 143 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81375953 |
| 144 | MAF_26560356_Chip-Seq_TH1_Human | 0.81228575 |
| 145 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.81173839 |
| 146 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81132178 |
| 147 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.79773116 |
| 148 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.79265763 |
| 149 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79233421 |
| 150 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78939268 |
| 151 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.78313956 |
| 152 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78246175 |
| 153 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.77641370 |
| 154 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77635770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.57003072 |
| 2 | MP0004043_abnormal_pH_regulation | 3.21111061 |
| 3 | MP0003436_decreased_susceptibility_to | 3.12755954 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.10665566 |
| 5 | MP0004270_analgesia | 2.99220977 |
| 6 | MP0003329_amyloid_beta_deposits | 2.96225063 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.93906083 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.68038758 |
| 9 | MP0004885_abnormal_endolymph | 2.64325881 |
| 10 | MP0002822_catalepsy | 2.63306618 |
| 11 | MP0003866_abnormal_defecation | 2.56272477 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 2.39582814 |
| 13 | MP0003690_abnormal_glial_cell | 2.36321130 |
| 14 | MP0003195_calcinosis | 2.22293541 |
| 15 | MP0001800_abnormal_humoral_immune | 2.14117098 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.08470707 |
| 17 | MP0008260_abnormal_autophagy | 2.07269316 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.05090771 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.04494727 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.02923175 |
| 21 | MP0004742_abnormal_vestibular_system | 1.94736604 |
| 22 | MP0002796_impaired_skin_barrier | 1.93363316 |
| 23 | MP0005310_abnormal_salivary_gland | 1.92445640 |
| 24 | MP0000703_abnormal_thymus_morphology | 1.90701854 |
| 25 | MP0003045_fibrosis | 1.88869489 |
| 26 | MP0008961_abnormal_basal_metabolism | 1.86906979 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.83331259 |
| 28 | MP0000604_amyloidosis | 1.81885659 |
| 29 | MP0002272_abnormal_nervous_system | 1.80638816 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.80287949 |
| 31 | MP0000685_abnormal_immune_system | 1.79733124 |
| 32 | MP0003724_increased_susceptibility_to | 1.76384433 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.73698857 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.73454633 |
| 35 | MP0001348_abnormal_lacrimal_gland | 1.73033300 |
| 36 | MP0001819_abnormal_immune_cell | 1.71527965 |
| 37 | MP0002064_seizures | 1.70687511 |
| 38 | MP0002723_abnormal_immune_serum | 1.70322592 |
| 39 | MP0003634_abnormal_glial_cell | 1.69423534 |
| 40 | MP0003635_abnormal_synaptic_transmissio | 1.68927223 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.68819071 |
| 42 | MP0005025_abnormal_response_to | 1.67647302 |
| 43 | MP0001485_abnormal_pinna_reflex | 1.66088803 |
| 44 | MP0003283_abnormal_digestive_organ | 1.65811165 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.63179190 |
| 46 | MP0001486_abnormal_startle_reflex | 1.62201142 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.59666724 |
| 48 | MP0002398_abnormal_bone_marrow | 1.58322049 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.54646561 |
| 50 | MP0003453_abnormal_keratinocyte_physiol | 1.53688888 |
| 51 | MP0003878_abnormal_ear_physiology | 1.53513654 |
| 52 | MP0005377_hearing/vestibular/ear_phenot | 1.53513654 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.52842579 |
| 54 | MP0002254_reproductive_system_inflammat | 1.52467201 |
| 55 | MP0008569_lethality_at_weaning | 1.52316146 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.51288489 |
| 57 | MP0000462_abnormal_digestive_system | 1.51098706 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.50444027 |
| 59 | MP0005360_urolithiasis | 1.49779215 |
| 60 | MP0000716_abnormal_immune_system | 1.48356944 |
| 61 | MP0001835_abnormal_antigen_presentation | 1.47482484 |
| 62 | MP0010678_abnormal_skin_adnexa | 1.45862344 |
| 63 | MP0002933_joint_inflammation | 1.42845486 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.40890616 |
| 65 | MP0003880_abnormal_central_pattern | 1.40588605 |
| 66 | MP0002009_preneoplasia | 1.39119169 |
| 67 | MP0002405_respiratory_system_inflammati | 1.38383036 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.36457198 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.32176515 |
| 70 | MP0002229_neurodegeneration | 1.32063525 |
| 71 | MP0009745_abnormal_behavioral_response | 1.29868879 |
| 72 | MP0002419_abnormal_innate_immunity | 1.28743110 |
| 73 | MP0001501_abnormal_sleep_pattern | 1.27599969 |
| 74 | MP0005451_abnormal_body_composition | 1.27596750 |
| 75 | MP0002722_abnormal_immune_system | 1.27281343 |
| 76 | MP0003303_peritoneal_inflammation | 1.25485925 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.23389605 |
| 78 | MP0004381_abnormal_hair_follicle | 1.21952839 |
| 79 | MP0009840_abnormal_foam_cell | 1.21022175 |
| 80 | MP0002396_abnormal_hematopoietic_system | 1.20066150 |
| 81 | MP0003633_abnormal_nervous_system | 1.19655218 |
| 82 | MP0002693_abnormal_pancreas_physiology | 1.19447800 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.18985338 |
| 84 | MP0000689_abnormal_spleen_morphology | 1.18709050 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 1.18503424 |
| 86 | MP0004510_myositis | 1.17254824 |
| 87 | MP0001873_stomach_inflammation | 1.16820272 |
| 88 | MP0005671_abnormal_response_to | 1.16008487 |
| 89 | MP0001849_ear_inflammation | 1.15887914 |
| 90 | MP0002063_abnormal_learning/memory/cond | 1.15703612 |
| 91 | MP0003879_abnormal_hair_cell | 1.13303762 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 1.13267376 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 1.12197541 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 1.11575405 |
| 95 | MP0002429_abnormal_blood_cell | 1.11099958 |
| 96 | MP0003091_abnormal_cell_migration | 1.10668639 |
| 97 | MP0004947_skin_inflammation | 1.10492187 |
| 98 | MP0001440_abnormal_grooming_behavior | 1.10257835 |
| 99 | MP0001851_eye_inflammation | 1.09506214 |
| 100 | MP0002734_abnormal_mechanical_nocicepti | 1.06877710 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 1.01418383 |
| 102 | MP0001944_abnormal_pancreas_morphology | 0.99361833 |
| 103 | MP0000955_abnormal_spinal_cord | 0.98049923 |
| 104 | MP0009785_altered_susceptibility_to | 0.97187044 |
| 105 | MP0003632_abnormal_nervous_system | 0.96703300 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.96594471 |
| 107 | MP0003631_nervous_system_phenotype | 0.96294906 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.96204121 |
| 109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95887018 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.95836312 |
| 111 | MP0002733_abnormal_thermal_nociception | 0.95826712 |
| 112 | MP0000858_altered_metastatic_potential | 0.95785817 |
| 113 | MP0000383_abnormal_hair_follicle | 0.95585392 |
| 114 | MP0006082_CNS_inflammation | 0.95260237 |
| 115 | MP0005387_immune_system_phenotype | 0.94995422 |
| 116 | MP0001790_abnormal_immune_system | 0.94995422 |
| 117 | MP0003252_abnormal_bile_duct | 0.94514259 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.93936257 |
| 119 | MP0001970_abnormal_pain_threshold | 0.93646149 |
| 120 | MP0005501_abnormal_skin_physiology | 0.92458358 |
| 121 | MP0003123_paternal_imprinting | 0.92087554 |
| 122 | MP0001853_heart_inflammation | 0.91764514 |
| 123 | MP0005365_abnormal_bile_salt | 0.90441718 |
| 124 | MP0009278_abnormal_bone_marrow | 0.88739708 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.87825036 |
| 126 | MP0002098_abnormal_vibrissa_morphology | 0.85396064 |
| 127 | MP0001502_abnormal_circadian_rhythm | 0.84434975 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.84085213 |
| 129 | MP0001905_abnormal_dopamine_level | 0.83255444 |
| 130 | MP0005410_abnormal_fertilization | 0.82768671 |
| 131 | MP0001664_abnormal_digestion | 0.81908767 |
| 132 | MP0002132_abnormal_respiratory_system | 0.80659764 |
| 133 | MP0009643_abnormal_urine_homeostasis | 0.80343752 |
| 134 | MP0005423_abnormal_somatic_nervous | 0.78893655 |
| 135 | MP0006072_abnormal_retinal_apoptosis | 0.77602219 |
| 136 | MP0002066_abnormal_motor_capabilities/c | 0.77592516 |
| 137 | MP0002139_abnormal_hepatobiliary_system | 0.77172430 |
| 138 | MP0001216_abnormal_epidermal_layer | 0.76854703 |
| 139 | MP0002882_abnormal_neuron_morphology | 0.76246344 |
| 140 | MP0000490_abnormal_crypts_of | 0.76194734 |
| 141 | MP0000678_abnormal_parathyroid_gland | 0.75483959 |
| 142 | MP0001663_abnormal_digestive_system | 0.74609530 |
| 143 | MP0005166_decreased_susceptibility_to | 0.74270360 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.73893444 |
| 145 | MP0005381_digestive/alimentary_phenotyp | 0.73892156 |
| 146 | MP0004924_abnormal_behavior | 0.73722944 |
| 147 | MP0005386_behavior/neurological_phenoty | 0.73722944 |
| 148 | MP0009115_abnormal_fat_cell | 0.73706887 |
| 149 | MP0001661_extended_life_span | 0.73696941 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.73326537 |
| 151 | MP0003075_altered_response_to | 0.73168359 |
| 152 | MP0000477_abnormal_intestine_morphology | 0.73004369 |
| 153 | MP0000609_abnormal_liver_physiology | 0.72642855 |
| 154 | MP0002148_abnormal_hypersensitivity_rea | 0.71838545 |
| 155 | MP0002168_other_aberrant_phenotype | 0.70882057 |
| 156 | MP0005535_abnormal_body_temperature | 0.70203469 |
| 157 | MP0010155_abnormal_intestine_physiology | 0.69790203 |
| 158 | MP0005409_darkened_coat_color | 0.69682562 |
| 159 | MP0005645_abnormal_hypothalamus_physiol | 0.69304400 |
| 160 | MP0008874_decreased_physiological_sensi | 0.68626702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.00611536 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.83485195 |
| 3 | Obstructive sleep apnea (HP:0002870) | 4.71501197 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.27004046 |
| 5 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.27004046 |
| 6 | Cerebral inclusion bodies (HP:0100314) | 3.92372521 |
| 7 | Peripheral hypomyelination (HP:0007182) | 3.89692623 |
| 8 | Pustule (HP:0200039) | 3.79766219 |
| 9 | Ankle clonus (HP:0011448) | 3.77084318 |
| 10 | Sensory axonal neuropathy (HP:0003390) | 3.76964997 |
| 11 | Papilledema (HP:0001085) | 3.56339019 |
| 12 | Spastic gait (HP:0002064) | 3.47871674 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.47740419 |
| 14 | Increased IgE level (HP:0003212) | 3.45708798 |
| 15 | Abnormality of the corticospinal tract (HP:0002492) | 3.42497955 |
| 16 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.32675146 |
| 17 | Onion bulb formation (HP:0003383) | 3.32296777 |
| 18 | Increased circulating renin level (HP:0000848) | 3.30590901 |
| 19 | Metabolic alkalosis (HP:0200114) | 3.13370379 |
| 20 | Myokymia (HP:0002411) | 3.13309202 |
| 21 | T lymphocytopenia (HP:0005403) | 3.05879385 |
| 22 | Hypokalemic alkalosis (HP:0001949) | 3.01307212 |
| 23 | Abnormality of the fingertips (HP:0001211) | 2.99623378 |
| 24 | Intention tremor (HP:0002080) | 2.98653267 |
| 25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.93039182 |
| 26 | Dysmetria (HP:0001310) | 2.92934198 |
| 27 | Broad face (HP:0000283) | 2.92514286 |
| 28 | Hypoglycemic seizures (HP:0002173) | 2.87111430 |
| 29 | Large for gestational age (HP:0001520) | 2.85445609 |
| 30 | Abnormality of T cell number (HP:0011839) | 2.76390034 |
| 31 | J-shaped sella turcica (HP:0002680) | 2.75800792 |
| 32 | Papilloma (HP:0012740) | 2.73130385 |
| 33 | Verrucae (HP:0200043) | 2.73130385 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.67902249 |
| 35 | Anteriorly placed anus (HP:0001545) | 2.66693231 |
| 36 | Myositis (HP:0100614) | 2.65537443 |
| 37 | Abnormal auditory evoked potentials (HP:0006958) | 2.57012628 |
| 38 | Thin bony cortex (HP:0002753) | 2.54799156 |
| 39 | Symptomatic seizures (HP:0011145) | 2.51126720 |
| 40 | Clonus (HP:0002169) | 2.47025179 |
| 41 | Chronic otitis media (HP:0000389) | 2.46156931 |
| 42 | Gastrointestinal stroma tumor (HP:0100723) | 2.45713923 |
| 43 | Slow saccadic eye movements (HP:0000514) | 2.45388281 |
| 44 | Premature skin wrinkling (HP:0100678) | 2.45373173 |
| 45 | Abnormality of renin-angiotensin system (HP:0000847) | 2.45074448 |
| 46 | Seborrheic dermatitis (HP:0001051) | 2.44360869 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.42071183 |
| 48 | Nasal polyposis (HP:0100582) | 2.39363245 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.35922357 |
| 50 | Megalencephaly (HP:0001355) | 2.34265129 |
| 51 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.29984389 |
| 52 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.29984389 |
| 53 | Malnutrition (HP:0004395) | 2.29825045 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.29083041 |
| 55 | Abnormality of chloride homeostasis (HP:0011422) | 2.28499986 |
| 56 | Germ cell neoplasia (HP:0100728) | 2.27922196 |
| 57 | Growth hormone excess (HP:0000845) | 2.26597638 |
| 58 | Abnormality of macrophages (HP:0004311) | 2.26324501 |
| 59 | Micronodular cirrhosis (HP:0001413) | 2.25105038 |
| 60 | Stridor (HP:0010307) | 2.24686034 |
| 61 | Insidious onset (HP:0003587) | 2.23078915 |
| 62 | Termporal pattern (HP:0011008) | 2.23078915 |
| 63 | Orchitis (HP:0100796) | 2.21649245 |
| 64 | Atonic seizures (HP:0010819) | 2.21465072 |
| 65 | Spinal canal stenosis (HP:0003416) | 2.19403234 |
| 66 | Macroorchidism (HP:0000053) | 2.19270230 |
| 67 | Stomatitis (HP:0010280) | 2.19005136 |
| 68 | Recurrent fungal infections (HP:0002841) | 2.18180300 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.17760461 |
| 70 | Cellulitis (HP:0100658) | 2.16490110 |
| 71 | Hemorrhage of the eye (HP:0011885) | 2.15376049 |
| 72 | Vasculitis (HP:0002633) | 2.15031952 |
| 73 | Thickened helices (HP:0000391) | 2.12538942 |
| 74 | Meningitis (HP:0001287) | 2.11294104 |
| 75 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.10948710 |
| 76 | Pheochromocytoma (HP:0002666) | 2.10239281 |
| 77 | Male infertility (HP:0003251) | 2.10080207 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.09600733 |
| 79 | Hyperkalemia (HP:0002153) | 2.08846985 |
| 80 | Colitis (HP:0002583) | 2.08756444 |
| 81 | Urinary urgency (HP:0000012) | 2.08464260 |
| 82 | Cerebral aneurysm (HP:0004944) | 2.07781939 |
| 83 | Action tremor (HP:0002345) | 2.06456753 |
| 84 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.06227722 |
| 85 | Subacute progressive viral hepatitis (HP:0006572) | 2.05013462 |
| 86 | Flat acetabular roof (HP:0003180) | 2.03251090 |
| 87 | Recurrent abscess formation (HP:0002722) | 2.02862670 |
| 88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01890901 |
| 89 | Gingivitis (HP:0000230) | 2.01871212 |
| 90 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01078587 |
| 91 | Lymphopenia (HP:0001888) | 2.00733139 |
| 92 | Scanning speech (HP:0002168) | 2.00648531 |
| 93 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00644528 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 2.00593762 |
| 95 | Cerebral hemorrhage (HP:0001342) | 2.00430006 |
| 96 | Spastic paraparesis (HP:0002313) | 2.00294566 |
| 97 | Clumsiness (HP:0002312) | 2.00275531 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 1.99036058 |
| 99 | Emphysema (HP:0002097) | 1.98350485 |
| 100 | Recurrent bacterial skin infections (HP:0005406) | 1.98322368 |
| 101 | Recurrent bronchitis (HP:0002837) | 1.97274881 |
| 102 | Abnormality of potassium homeostasis (HP:0011042) | 1.96500100 |
| 103 | Hypokalemia (HP:0002900) | 1.94947717 |
| 104 | Hyperparathyroidism (HP:0000843) | 1.94798261 |
| 105 | Testicular neoplasm (HP:0010788) | 1.94401912 |
| 106 | Basal cell carcinoma (HP:0002671) | 1.93972203 |
| 107 | Hyperactive renin-angiotensin system (HP:0000841) | 1.93051209 |
| 108 | Deep venous thrombosis (HP:0002625) | 1.92923558 |
| 109 | Ileus (HP:0002595) | 1.92432367 |
| 110 | Dysostosis multiplex (HP:0000943) | 1.91266748 |
| 111 | Retrobulbar optic neuritis (HP:0100654) | 1.89781119 |
| 112 | Optic neuritis (HP:0100653) | 1.89781119 |
| 113 | Hypomagnesemia (HP:0002917) | 1.89471689 |
| 114 | Interstitial pulmonary disease (HP:0006530) | 1.89111060 |
| 115 | Decreased circulating renin level (HP:0003351) | 1.88999667 |
| 116 | Increased CSF protein (HP:0002922) | 1.86572554 |
| 117 | Prolonged bleeding time (HP:0003010) | 1.86061363 |
| 118 | Neonatal hypoglycemia (HP:0001998) | 1.84355744 |
| 119 | Easy fatigability (HP:0003388) | 1.84164500 |
| 120 | Hemiplegia (HP:0002301) | 1.83960741 |
| 121 | Chronic diarrhea (HP:0002028) | 1.83262373 |
| 122 | Annular pancreas (HP:0001734) | 1.83247316 |
| 123 | Dislocated radial head (HP:0003083) | 1.82737163 |
| 124 | Abnormality of oral frenula (HP:0000190) | 1.82460743 |
| 125 | Lower limb muscle weakness (HP:0007340) | 1.82322497 |
| 126 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82172399 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82172399 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82172399 |
| 129 | Abnormality of T cells (HP:0002843) | 1.82036261 |
| 130 | Cerebral hypomyelination (HP:0006808) | 1.82032890 |
| 131 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.81183711 |
| 132 | Spastic tetraparesis (HP:0001285) | 1.80975642 |
| 133 | Alacrima (HP:0000522) | 1.80959030 |
| 134 | Distal upper limb amyotrophy (HP:0007149) | 1.80600566 |
| 135 | Upper limb amyotrophy (HP:0009129) | 1.80600566 |
| 136 | Hypercortisolism (HP:0001578) | 1.80405774 |
| 137 | Hyperphosphatemia (HP:0002905) | 1.79920108 |
| 138 | Mediastinal lymphadenopathy (HP:0100721) | 1.79873772 |
| 139 | Hypoglycemic coma (HP:0001325) | 1.79123510 |
| 140 | Spontaneous hematomas (HP:0007420) | 1.78612394 |
| 141 | Turricephaly (HP:0000262) | 1.78197857 |
| 142 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77613247 |
| 143 | Hyporeflexia of lower limbs (HP:0002600) | 1.77394710 |
| 144 | Visual hallucinations (HP:0002367) | 1.77341598 |
| 145 | Polygenic inheritance (HP:0010982) | 1.76061947 |
| 146 | Recurrent otitis media (HP:0000403) | 1.75051606 |
| 147 | Recurrent viral infections (HP:0004429) | 1.74644994 |
| 148 | Deformed sella turcica (HP:0002681) | 1.73911813 |
| 149 | Lower limb asymmetry (HP:0100559) | 1.73638555 |
| 150 | Abnormality of the radial head (HP:0003995) | 1.73198701 |
| 151 | Neuronal loss in central nervous system (HP:0002529) | 1.72226224 |
| 152 | Ocular albinism (HP:0001107) | 1.71798515 |
| 153 | Asymmetry of the thorax (HP:0001555) | 1.69433828 |
| 154 | Restrictive lung disease (HP:0002091) | 1.68855244 |
| 155 | Villous atrophy (HP:0011473) | 1.68248732 |
| 156 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.68248732 |
| 157 | Distal sensory impairment (HP:0002936) | 1.67610680 |
| 158 | Mucopolysacchariduria (HP:0008155) | 1.66758155 |
| 159 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.66758155 |
| 160 | Alkalosis (HP:0001948) | 1.66462187 |
| 161 | Xanthomatosis (HP:0000991) | 1.66319952 |
| 162 | Renal salt wasting (HP:0000127) | 1.63473469 |
| 163 | Joint swelling (HP:0001386) | 1.63394383 |
| 164 | Protuberant abdomen (HP:0001538) | 1.63215322 |
| 165 | Overriding aorta (HP:0002623) | 1.63025628 |
| 166 | Pulmonary infiltrates (HP:0002113) | 1.62943118 |
| 167 | Abdominal distention (HP:0003270) | 1.62558792 |
| 168 | Decreased motor nerve conduction velocity (HP:0003431) | 1.60739078 |
| 169 | Focal motor seizures (HP:0011153) | 1.60716364 |
| 170 | Abnormality of saccadic eye movements (HP:0000570) | 1.60512007 |
| 171 | Postural tremor (HP:0002174) | 1.60178892 |
| 172 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.60045647 |
| 173 | Abnormality of magnesium homeostasis (HP:0004921) | 1.59240004 |
| 174 | Hyperaldosteronism (HP:0000859) | 1.58848176 |
| 175 | Focal seizures (HP:0007359) | 1.58748048 |
| 176 | Paraparesis (HP:0002385) | 1.57984062 |
| 177 | Neuroendocrine neoplasm (HP:0100634) | 1.57185930 |
| 178 | Hammertoe (HP:0001765) | 1.56416376 |
| 179 | Ketoacidosis (HP:0001993) | 1.56259782 |
| 180 | Abnormal tarsal ossification (HP:0008369) | 1.55591601 |
| 181 | Humeroradial synostosis (HP:0003041) | 1.55354734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.81165256 |
| 2 | EPHB1 | 3.13426735 |
| 3 | WNK4 | 2.87948682 |
| 4 | ERN1 | 2.67138859 |
| 5 | MAP4K1 | 2.51232467 |
| 6 | OXSR1 | 2.48225853 |
| 7 | TXK | 2.45107647 |
| 8 | SMG1 | 2.40459578 |
| 9 | PRKD3 | 2.40319406 |
| 10 | SIK3 | 2.31561481 |
| 11 | TYRO3 | 2.27540949 |
| 12 | ICK | 2.19321800 |
| 13 | ITK | 2.09651968 |
| 14 | WNK1 | 2.09334950 |
| 15 | MAP3K10 | 2.07168049 |
| 16 | MAP3K2 | 2.03594123 |
| 17 | PRKCH | 1.94729363 |
| 18 | RIPK4 | 1.75759846 |
| 19 | SIK2 | 1.70522794 |
| 20 | MAPK15 | 1.70292665 |
| 21 | FGFR2 | 1.64862645 |
| 22 | NTRK1 | 1.62844967 |
| 23 | PRPF4B | 1.55090163 |
| 24 | EPHA2 | 1.54875770 |
| 25 | MST4 | 1.54435174 |
| 26 | TYK2 | 1.48515668 |
| 27 | FGFR4 | 1.45375149 |
| 28 | KSR2 | 1.43120672 |
| 29 | PAK6 | 1.33918973 |
| 30 | EEF2K | 1.33601308 |
| 31 | PKN2 | 1.32237314 |
| 32 | EPHA4 | 1.30059226 |
| 33 | MET | 1.29291518 |
| 34 | UHMK1 | 1.28480029 |
| 35 | INSRR | 1.26192551 |
| 36 | MAP3K3 | 1.25092330 |
| 37 | HIPK2 | 1.20573083 |
| 38 | PRKCQ | 1.18400451 |
| 39 | MARK2 | 1.15369659 |
| 40 | PAK3 | 1.14357621 |
| 41 | PASK | 1.12448344 |
| 42 | MAP3K14 | 1.11655650 |
| 43 | IRAK4 | 1.11503617 |
| 44 | PRKD2 | 1.11466013 |
| 45 | STK10 | 1.09852692 |
| 46 | MAP2K2 | 1.08640483 |
| 47 | BTK | 1.07911166 |
| 48 | NEK6 | 1.07437390 |
| 49 | JAK1 | 1.04454770 |
| 50 | MAP3K13 | 1.04453838 |
| 51 | MAP3K9 | 1.03581748 |
| 52 | GRK6 | 1.02268469 |
| 53 | MAP3K1 | 0.99145932 |
| 54 | SGK494 | 0.98712818 |
| 55 | SGK223 | 0.98712818 |
| 56 | CSNK1A1L | 0.98234709 |
| 57 | TBK1 | 0.97555092 |
| 58 | CDK19 | 0.95785401 |
| 59 | TNIK | 0.95197008 |
| 60 | MAP3K7 | 0.93867060 |
| 61 | CAMK2B | 0.90499846 |
| 62 | STK38 | 0.89987191 |
| 63 | STK11 | 0.89883431 |
| 64 | PKN1 | 0.89736957 |
| 65 | ROCK2 | 0.89671732 |
| 66 | PDPK1 | 0.89608358 |
| 67 | CDK5 | 0.88345899 |
| 68 | MAP2K3 | 0.88038427 |
| 69 | PTK2 | 0.87896805 |
| 70 | TRIB3 | 0.85728444 |
| 71 | CLK1 | 0.85634248 |
| 72 | MAPK12 | 0.84487323 |
| 73 | BCR | 0.84362193 |
| 74 | PDK1 | 0.84358088 |
| 75 | CSK | 0.82863550 |
| 76 | ALK | 0.82177541 |
| 77 | PTK6 | 0.81927445 |
| 78 | PDGFRB | 0.81003771 |
| 79 | NTRK3 | 0.80749227 |
| 80 | ZAP70 | 0.77505310 |
| 81 | RET | 0.77476052 |
| 82 | CHUK | 0.76833175 |
| 83 | TAOK1 | 0.75044443 |
| 84 | PRKD1 | 0.71582148 |
| 85 | CSNK1G2 | 0.71253589 |
| 86 | IRAK2 | 0.70812726 |
| 87 | NLK | 0.70596197 |
| 88 | DMPK | 0.69094390 |
| 89 | CAMK1G | 0.69069451 |
| 90 | CSNK1G1 | 0.68735675 |
| 91 | CDK12 | 0.68167905 |
| 92 | JAK2 | 0.67656812 |
| 93 | MELK | 0.67167679 |
| 94 | IKBKE | 0.66931107 |
| 95 | JAK3 | 0.66916374 |
| 96 | FYN | 0.66552072 |
| 97 | NTRK2 | 0.66529761 |
| 98 | CSNK1G3 | 0.66366683 |
| 99 | LCK | 0.66221691 |
| 100 | MAPKAPK3 | 0.66102945 |
| 101 | CAMKK2 | 0.65000625 |
| 102 | MAP3K11 | 0.64311806 |
| 103 | MARK3 | 0.63925216 |
| 104 | RPS6KB2 | 0.63869910 |
| 105 | MAPK11 | 0.63783088 |
| 106 | RIPK1 | 0.63775410 |
| 107 | MTOR | 0.61222852 |
| 108 | FES | 0.60722140 |
| 109 | CAMKK1 | 0.59738263 |
| 110 | TESK1 | 0.59328129 |
| 111 | MST1R | 0.58746513 |
| 112 | LRRK2 | 0.58037362 |
| 113 | IKBKB | 0.57962619 |
| 114 | TAOK3 | 0.57813546 |
| 115 | MAP2K6 | 0.57102246 |
| 116 | CAMK2D | 0.56904542 |
| 117 | SIK1 | 0.56165671 |
| 118 | MAPK7 | 0.55523516 |
| 119 | PNCK | 0.55311021 |
| 120 | IRAK1 | 0.55289524 |
| 121 | LMTK2 | 0.53673290 |
| 122 | FGFR3 | 0.53176408 |
| 123 | IRAK3 | 0.53107464 |
| 124 | SGK3 | 0.52685416 |
| 125 | WNK3 | 0.52412001 |
| 126 | TAOK2 | 0.51547869 |
| 127 | BMX | 0.49480443 |
| 128 | FGR | 0.49239726 |
| 129 | CAMK2G | 0.49079445 |
| 130 | SGK2 | 0.48453590 |
| 131 | EPHA3 | 0.47695159 |
| 132 | RPS6KA2 | 0.46749481 |
| 133 | DYRK1B | 0.46432663 |
| 134 | SYK | 0.45762534 |
| 135 | PIK3CA | 0.45224310 |
| 136 | HCK | 0.44853927 |
| 137 | FGFR1 | 0.42388861 |
| 138 | TNK2 | 0.41823958 |
| 139 | CDC42BPA | 0.41551343 |
| 140 | BRD4 | 0.40709619 |
| 141 | CSNK1A1 | 0.39146122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.59357861 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.48143725 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.32981299 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.29611161 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.93907569 |
| 6 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.71986497 |
| 7 | Endometrial cancer_Homo sapiens_hsa05213 | 1.68379765 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66346076 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 1.63673606 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58658129 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57543767 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55826160 |
| 13 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.54787219 |
| 14 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.54271287 |
| 15 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.44595705 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43244007 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.38432473 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.36280644 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.35142163 |
| 20 | Hepatitis C_Homo sapiens_hsa05160 | 1.34760787 |
| 21 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.34595383 |
| 22 | Thyroid cancer_Homo sapiens_hsa05216 | 1.33891855 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33214093 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32747346 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.29707023 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27636587 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.27551433 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.24250923 |
| 29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23417533 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22871194 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22327935 |
| 32 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.22182610 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.22070721 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20865465 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.20304593 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.18901285 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.18234892 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17366897 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 1.16619213 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.15031075 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14861553 |
| 42 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.13125264 |
| 43 | Colorectal cancer_Homo sapiens_hsa05210 | 1.12648045 |
| 44 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.12241534 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10637881 |
| 46 | GABAergic synapse_Homo sapiens_hsa04727 | 1.10272910 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.08409609 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07894199 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07600500 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.07248109 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06842571 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05365440 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05068710 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04654393 |
| 55 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.04144675 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 1.03601572 |
| 57 | Morphine addiction_Homo sapiens_hsa05032 | 1.03582887 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03533100 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02522772 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01216313 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 1.00620880 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00598806 |
| 63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.99991190 |
| 64 | Prostate cancer_Homo sapiens_hsa05215 | 0.99857007 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.99411075 |
| 66 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.99189336 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98061502 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97574562 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.96682791 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95723868 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.95558380 |
| 72 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94329793 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94317584 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.93332728 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92112277 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.91438391 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.89375209 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87708844 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87376660 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86857226 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86447656 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85551780 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.85307239 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84872066 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83581605 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81781138 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81441624 |
| 88 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.78845343 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78185378 |
| 90 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77548597 |
| 91 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77119458 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77115486 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76828034 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76811027 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76703526 |
| 96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76583189 |
| 97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76463476 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74894281 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73970194 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73493127 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71560248 |
| 102 | Allograft rejection_Homo sapiens_hsa05330 | 0.71088999 |
| 103 | Long-term depression_Homo sapiens_hsa04730 | 0.69588806 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.69374589 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69088074 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68690318 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.68620749 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.68196141 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68105949 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.67051487 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66682434 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65927881 |
| 113 | Protein export_Homo sapiens_hsa03060 | 0.65291566 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65214929 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65194724 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65136985 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64212483 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63120229 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62743315 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62191621 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62095534 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61749988 |
| 123 | Lysosome_Homo sapiens_hsa04142 | 0.60586727 |
| 124 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60122788 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59687924 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59635915 |
| 127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58990141 |
| 128 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58854089 |
| 129 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58742417 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.57976380 |
| 131 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57449645 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.57419763 |
| 133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57152845 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.57106553 |
| 135 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56937227 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55434227 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54986353 |
| 138 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54681361 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54581986 |
| 140 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53203794 |
| 141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52489102 |
| 142 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51956771 |
| 143 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51540178 |
| 144 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51359187 |
| 145 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50726055 |
| 146 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50404183 |
| 147 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50354882 |
| 148 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48513340 |
| 149 | Taste transduction_Homo sapiens_hsa04742 | 0.47290480 |
| 150 | Lysine degradation_Homo sapiens_hsa00310 | 0.47043513 |
| 151 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46728314 |
| 152 | Gap junction_Homo sapiens_hsa04540 | 0.46323769 |
| 153 | Asthma_Homo sapiens_hsa05310 | 0.46294436 |
| 154 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45802332 |
| 155 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43565048 |

